---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-023111"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:41:25.029495+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# PowerUp Acquisition amends merger with Visiox: Outside Date extended to June 30, 2024

## Summary
- Outside Date moved from May 31 to June 30, 2024; PowerUp's indebtedness cap increased to $2M.
- Net tangible asset test eliminated; minimum cash condition reduced from $5M to $1.00.
- Visiox must use best efforts to complete labeling/compliance for inventory by June 30, 2024.
- Visiox must raise at least $500K capital by June 30; $350K allocated to labeling project.
- From May 30 to closing, Visiox cannot make expenditures over $1K without PowerUp's approval.

## SEC filing metadata
- accession: 0001493152-24-023111
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000149315224023111/0001493152-24-023111-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000149315224023111/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-023111
- JSON: https://secwatch.observer/filing/0001493152-24-023111.json
- Plain text: https://secwatch.observer/filing/0001493152-24-023111.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.